Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on the minutes of the Board of Directors meeting held on March 26, 2018. The filing primarily addresses corporate governance actions, including the proposal for the allocation of net profits for the fiscal year ended December 31, 2017, and the convening of Ordinary and Extraordinary General Meetings scheduled for April 27, 2018.
Key Financial Metrics
The filing provides specific figures regarding profit allocation and capitalization but does not contain a full income statement or balance sheet for the period.
- Net Profits (FY 2017): R$ 7,331,968,165.59
- Dividends and Interest on Own Capital (Gross): R$ 4,712,417,426.89 (declared based on FY 2017 net profit). The total gross amount including expired dividends and prior reserves was R$ 8,482,560,807.61.
- Tax Incentives Reserve Allocation: R$ 1,552,260,808.80
- Investments Reserve Allocation: R$ 1,177,869,530.89
- Capital Stock Increase: Issuance of 4,531,892 new common shares (1,193,969 from 2018.2 Program and 3,337,923 from 2013.1 Program) for a total issuance price of R$ 96,062,067.44.
- Management Compensation Cap (2018): Up to R$ 83,292,928.00 for managers and R$ 2,041,187.00 for the Fiscal Council.
Note: The filing text does not provide clear values for revenue, operating margins, cash flow, debt levels, or liquidity ratios.
Material Changes and Corporate Actions
- Profit Allocation Proposal: The Board unanimously resolved to propose the allocation of FY 2017 net profits to shareholders, including significant dividends and interest on own capital.
- Capital Structure Change: The capital stock increased from R$ 57,614,139,847.33 to R$ 57,710,201,914.77 following the exercise of stock options under two different programs.
- Corporate Reorganization: The Board approved the terms for the partial spin-off of Arosuco Aromas e Sucos Ltda. and the subsequent merger of the spun-off portion into Ambev S.A.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or specific risk factors beyond the standard corporate actions. The primary focus is on the ratification of past performance (FY 2017) and the execution of governance procedures.
- Upcoming Events: Shareholders are invited to the Ordinary and Extraordinary General Meetings on April 27, 2018, to vote on the profit allocation, election of the Fiscal Council, management compensation, and the Arosuco merger.
- Valuation Contingency: The Arosuco merger is contingent upon the approval of a valuation report prepared by APSIS Consultoria e Avaliações Ltda., based on book value.
Investor Verification Checklist
- Verify the final approval of the FY 2017 dividend and interest on own capital payments at the April 27, 2018 General Meeting.
- Confirm the completion of the Arosuco Aromas e Sucos Ltda. spin-off and merger process.
- Review the full FY 2017 financial statements (published March 1, 2018) for detailed revenue, margin, and debt data not included in this summary.
- Monitor the impact of the new share issuance (approx. 4.5 million shares) on earnings per share and capital structure.